Trump Issues Executive Order to Fast-Track Psychedelic Drug Research for Veterans and Mental Health
President Donald Trump has signed an executive order directing the FDA to accelerate research and potential approval of psychedelic drugs,…
AbbVie Announces $380 Million Expansion for North Chicago Drug Manufacturing
AbbVie has unveiled plans to invest $380 million in two new active pharmaceutical ingredient (API) manufacturing facilities at its North…
FDA Proposes Streamlined Pathway for Rare Disease Drug Approvals
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory framework aimed at accelerating the approval of customized therapies…
Weight-Loss Drugs Lead Users to Rediscover Joy in Exercise
A growing number of Americans taking GLP-1 weight-loss drugs such as Wegovy and Ozempic report a profound shift in their relationship with…
Lindsey Vonn Credits Surgery for Saving Leg After Olympic Crash
Olympic skier Lindsey Vonn revealed she nearly lost her left leg after a severe crash during the Milan Cortina Olympics. In a candid Instagram…
Unregulated Peptide Injections Surge Despite Safety Concerns
A growing number of wellness enthusiasts and influencers are promoting injectable peptides for benefits ranging from muscle growth to…
Debate Intensifies Over Anxiety Medications as RFK Jr. Criticizes SSRIs
The use of anxiety medications in the U.S. has surged in recent years, with millions more Americans turning to SSRIs and other treatments,…
Gilead Sciences to Acquire Arcellx in $7.8 Billion Cell Therapy Deal
Gilead Sciences has announced plans to acquire Arcellx, a cancer therapy developer, for an implied equity value of $7.8 billion. The deal will…
Expectant Mother Faces Family Pushback Over Baby Vaccination Rules
An expectant mother in Washington is grappling with family resistance after following her doctor’s advice that all visitors to her newborn be…
Novo Nordisk Shares Plunge After Weight Loss Drug Trial Falls Short Against Eli Lilly Rival
Novo Nordisk’s stock plummeted 15% after its experimental weight loss drug, CagriSema, failed to match the efficacy of Eli Lilly’s tirzepatide…